)

Medicure (MPH) investor relations material
Medicure Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Net revenue for Q2 2025 was $6.7M, up from $5.2M in Q2 2024, driven by growth in ZYPITAMAG, Marley Drug, and new pharmacy acquisitions including Gateway and West Olympia.
Net loss narrowed to $786K ($0.08/share) from $1.1M ($0.12/share) year-over-year, with adjusted EBITDA improving to negative $28K from negative $514K.
Revenue growth was driven by Marley Drug, Gateway Pharmacy, and West Olympia Pharmacy acquisitions.
Strategic focus includes expanding pharmacy operations, growing ZYPITAMAG and Marley Drug, maintaining AGGRASTAT sales, and advancing R&D for MC1 and new chemical entities.
R&D investment of $741K focused on advancing MC-1 for PNPO deficiency.
Financial highlights
ZYPITAMAG sales rose 21% year-over-year to $1.7M, with Marley Drug sales up 15% to $3.1M.
AGGRASTAT revenue declined slightly to $1.7M due to increased generic competition.
Gateway and West Olympia Pharmacy acquisitions contributed $1.1M in Q2 revenue.
Gross profit for the quarter was $3.4M, up from $3.0M year-over-year.
Cash balance at quarter-end was $4.7M, down from $7.2M at year-end, mainly due to acquisitions; company remains debt-free.
Outlook and guidance
Short-term goals: grow ZYPITAMAG and Marley Drug, expand pharmacy business, maintain AGGRASTAT sales, and advance MC1 to FDA approval.
Plans to offer ZYPITAMAG and other products through newly acquired pharmacies in future quarters.
Continued focus on expanding product offerings and increasing utilization through insurance formularies.
Long-term focus on developing new intellectual property and diversifying revenue through R&D and further acquisitions.
Next Medicure earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage